GE HealthCare Technologies Investing Cash Flow decreased by 829.4% to -$2.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 514.3%, from -$407.00M to -$2.50B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -12.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$440.25M | -$440.25M | -$440.25M | -$100.00M | -$85.00M | -$118.00M | -$95.00M | -$266.00M | -$84.00M | -$120.00M | -$88.00M | -$188.00M | -$349.00M | -$137.00M | -$240.00M | -$407.00M | -$223.00M | -$148.00M | -$269.00M | -$2.50B |
| QoQ Change | — | +0.0% | +0.0% | +77.3% | +15.0% | -38.8% | +19.5% | -180.0% | +68.4% | -42.9% | +26.7% | -113.6% | -85.6% | +60.7% | -75.2% | -69.6% | +45.2% | +33.6% | -81.8% | -829.4% |
| YoY Change | — | — | — | — | +80.7% | +73.2% | +78.4% | -166.0% | +1.2% | -1.7% | +7.4% | +29.3% | -315.5% | -14.2% | -172.7% | -116.5% | +36.1% | -8.0% | -12.1% | -514.3% |